HPV Vaccine Also Prevents Cancers in Men, JAMA Oncology Report Shows

A report in JAMA Oncology highlights that the Human Papillomavirus (HPV) vaccination significantly decreased head and neck, esophageal, anal, and penile cancers in men over a nine-year period. This finding expands on the vaccine's known effectiveness in reducing cervical cancer in women, underscoring its broader public health benefit.